# Sypris Solutions Inc: financial statements, quarterly

SYPR · Nasdaq · CIK 864240 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sypr.md) · [Financials](/companies/sypr/financials.md) · [Filings](/companies/sypr/filings.md) · [Insiders](/companies/sypr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sypr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [33.6](/filings/0001437749-24-034416.md) | [34.7 d](/filings/0001437749-25-009524.md) | [35.6](/filings/0001437749-25-016842.md) | [35.5](/filings/0001437749-25-026096.md) | [35.7](/filings/0001437749-25-034293.md) | [33.4 d](/filings/0001437749-26-009882.md) | [29.5](/filings/0001437749-26-017727.md) | [31.4](/filings/0001437749-26-028271.md) | [28.7](/filings/0001437749-25-034293.md) | [30.3 d](/filings/0001437749-26-009882.md) | [25.8](/filings/0001437749-26-017727.md) | [30.3](/filings/0001437749-26-028271.md) |
| Cost of revenue | $m | [29.5](/filings/0001437749-24-034416.md) | [30.4 d](/filings/0001437749-25-009524.md) | [32.7](/filings/0001437749-25-016842.md) | [29.9](/filings/0001437749-25-026096.md) | [29.7](/filings/0001437749-25-034293.md) | [28.1 d](/filings/0001437749-26-009882.md) | [26.1](/filings/0001437749-26-017727.md) | [28.8](/filings/0001437749-26-028271.md) | [26.6](/filings/0001437749-25-034293.md) | [28.9 d](/filings/0001437749-26-009882.md) | [25.0](/filings/0001437749-26-017727.md) | [28.4](/filings/0001437749-26-028271.md) |
| Gross profit | $m | [4.0](/filings/0001437749-24-034416.md) | [4.4 d](/filings/0001437749-25-009524.md) | [2.9](/filings/0001437749-25-016842.md) | [5.6](/filings/0001437749-25-026096.md) | [6.0](/filings/0001437749-25-034293.md) | [5.4 d](/filings/0001437749-26-009882.md) | [3.4](/filings/0001437749-26-017727.md) | [2.6](/filings/0001437749-26-028271.md) | [2.1](/filings/0001437749-25-034293.md) | [1.4 d](/filings/0001437749-26-009882.md) | [0.8](/filings/0001437749-26-017727.md) | [2.0](/filings/0001437749-26-028271.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [4.2](/filings/0001437749-24-034416.md) | [4.7 d](/filings/0001437749-25-009524.md) | [4.3](/filings/0001437749-25-016842.md) | [4.4](/filings/0001437749-25-026096.md) | [4.3](/filings/0001437749-25-034293.md) | [4.1 d](/filings/0001437749-26-009882.md) | [3.5](/filings/0001437749-26-017727.md) | [4.0](/filings/0001437749-26-028271.md) | [3.8](/filings/0001437749-25-034293.md) | [4.7 d](/filings/0001437749-26-009882.md) | [4.4](/filings/0001437749-26-017727.md) | [4.4](/filings/0001437749-26-028271.md) |
| Operating income | $m | [(0.1)](/filings/0001437749-24-034416.md) | [(0.3) d](/filings/0001437749-25-009524.md) | [(1.4)](/filings/0001437749-25-016842.md) | [1.3](/filings/0001437749-25-026096.md) | [1.7](/filings/0001437749-25-034293.md) | [1.3 d](/filings/0001437749-26-009882.md) | [(0.1)](/filings/0001437749-26-017727.md) | [(1.4)](/filings/0001437749-26-028271.md) | [(1.7)](/filings/0001437749-25-034293.md) | [(3.3) d](/filings/0001437749-26-009882.md) | [(3.6)](/filings/0001437749-26-017727.md) | [(2.5)](/filings/0001437749-26-028271.md) |
| Interest expense | $m | [0.1](/filings/0001437749-23-032162.md) | [0.2 d](/filings/0001437749-24-010216.md) | [0.3](/filings/0001437749-24-016886.md) | [0.6](/filings/0001437749-24-026231.md) | [0.5](/filings/0001437749-25-034293.md) | [0.2 d](/filings/0001437749-26-009882.md) | [0.3](/filings/0001437749-26-017727.md) | [0.4](/filings/0001437749-26-028271.md) | [0.4](/filings/0001437749-25-034293.md) | [0.6 d](/filings/0001437749-26-009882.md) | [0.5](/filings/0001437749-26-017727.md) | [0.5](/filings/0001437749-26-028271.md) |
| Income tax | $m | [0.1](/filings/0001437749-24-034416.md) | [0.2 d](/filings/0001437749-25-009524.md) | [0.2](/filings/0001437749-25-016842.md) | [0.5](/filings/0001437749-25-026096.md) | [0.5](/filings/0001437749-25-034293.md) | [0.5 d](/filings/0001437749-26-009882.md) | [0.3](/filings/0001437749-26-017727.md) | [0.0](/filings/0001437749-26-028271.md) | [(0.2)](/filings/0001437749-25-034293.md) | [(0.1) d](/filings/0001437749-26-009882.md) | [(0.1)](/filings/0001437749-26-017727.md) | [(0.0)](/filings/0001437749-26-028271.md) |
| Net income | $m | [(0.6)](/filings/0001437749-24-034416.md) | [(1.1) d](/filings/0001437749-25-009524.md) | [(2.2)](/filings/0001437749-25-016842.md) | [0.0](/filings/0001437749-25-026096.md) | [0.4](/filings/0001437749-25-034293.md) | [0.1 d](/filings/0001437749-26-009882.md) | [(0.9)](/filings/0001437749-26-017727.md) | [(2.1)](/filings/0001437749-26-028271.md) | [0.5](/filings/0001437749-25-034293.md) | [(3.9) d](/filings/0001437749-26-009882.md) | [(4.1)](/filings/0001437749-26-017727.md) | [(3.1)](/filings/0001437749-26-028271.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001437749-24-034416.md) | not reported | [(0.10)](/filings/0001437749-25-016842.md) | [0.00](/filings/0001437749-25-026096.md) | [0.02](/filings/0001437749-25-034293.md) | not reported | [(0.04)](/filings/0001437749-26-017727.md) | [(0.09)](/filings/0001437749-26-028271.md) | [0.02](/filings/0001437749-25-034293.md) | not reported | [(0.18)](/filings/0001437749-26-017727.md) | [(0.14)](/filings/0001437749-26-028271.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001437749-24-034416.md) | not reported | [(0.10)](/filings/0001437749-25-016842.md) | [0.00](/filings/0001437749-25-026096.md) | [0.02](/filings/0001437749-25-034293.md) | not reported | [(0.04)](/filings/0001437749-26-017727.md) | [(0.09)](/filings/0001437749-26-028271.md) | [0.02](/filings/0001437749-25-034293.md) | not reported | [(0.18)](/filings/0001437749-26-017727.md) | [(0.14)](/filings/0001437749-26-028271.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [105](/filings/0001437749-23-032162.md) | [104](/filings/0001437749-25-009524.md) | [103](/filings/0001437749-24-016886.md) | [100](/filings/0001437749-24-026231.md) | [99.4](/filings/0001437749-24-034416.md) | [98.0](/filings/0001437749-26-009882.md) | [89.9](/filings/0001437749-25-016842.md) | [85.3](/filings/0001437749-25-026096.md) | [84.4](/filings/0001437749-25-034293.md) | [79.9](/filings/0001437749-26-028271.md) | [77.8](/filings/0001437749-26-017727.md) | [78.0](/filings/0001437749-26-028271.md) |
| Total assets | $m | [130](/filings/0001437749-23-032162.md) | [129](/filings/0001437749-25-009524.md) | [129](/filings/0001437749-24-016886.md) | [124](/filings/0001437749-24-026231.md) | [122](/filings/0001437749-24-034416.md) | [119](/filings/0001437749-26-009882.md) | [110](/filings/0001437749-25-016842.md) | [106](/filings/0001437749-25-026096.md) | [112](/filings/0001437749-25-034293.md) | [108](/filings/0001437749-26-028271.md) | [105](/filings/0001437749-26-017727.md) | [105](/filings/0001437749-26-028271.md) |
| Current liabilities | $m | [85.0](/filings/0001437749-23-032162.md) | [86.5](/filings/0001437749-25-009524.md) | [88.5](/filings/0001437749-24-016886.md) | [78.6](/filings/0001437749-24-026231.md) | [78.8](/filings/0001437749-24-034416.md) | [79.5](/filings/0001437749-26-009882.md) | [69.5](/filings/0001437749-25-016842.md) | [61.8](/filings/0001437749-25-026096.md) | [54.7](/filings/0001437749-25-034293.md) | [62.4](/filings/0001437749-26-028271.md) | [65.0](/filings/0001437749-26-017727.md) | [61.9](/filings/0001437749-26-028271.md) |
| Total liabilities | $m | [108](/filings/0001437749-23-032162.md) | [107](/filings/0001437749-25-009524.md) | [108](/filings/0001437749-24-016886.md) | [105](/filings/0001437749-24-026231.md) | [103](/filings/0001437749-24-034416.md) | [99.8](/filings/0001437749-26-009882.md) | [91.2](/filings/0001437749-25-016842.md) | [87.2](/filings/0001437749-25-026096.md) | [92.5](/filings/0001437749-25-034293.md) | [90.0](/filings/0001437749-26-028271.md) | [91.4](/filings/0001437749-26-017727.md) | [93.5](/filings/0001437749-26-028271.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [21.4](/filings/0001437749-23-032162.md) | [22.5](/filings/0001437749-25-009524.md) | [20.8](/filings/0001437749-24-016886.md) | [19.0](/filings/0001437749-24-026231.md) | [18.2](/filings/0001437749-24-034416.md) | [19.6](/filings/0001437749-26-009882.md) | [19.0](/filings/0001437749-25-016842.md) | [18.7](/filings/0001437749-25-026096.md) | [20.0](/filings/0001437749-25-034293.md) | [17.8](/filings/0001437749-26-028271.md) | [13.8](/filings/0001437749-26-017727.md) | [11.7](/filings/0001437749-26-028271.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(11.9) d](/filings/0001437749-24-034416.md) | [(2.9) d](/filings/0001437749-25-009524.md) | [(1.7)](/filings/0001437749-25-016842.md) | [6.2 d](/filings/0001437749-25-026096.md) | [(4.8) d](/filings/0001437749-25-034293.md) | [2.3 d](/filings/0001437749-26-009882.md) | [(5.5)](/filings/0001437749-26-017727.md) | [1.1 d](/filings/0001437749-26-028271.md) | [(0.2) d](/filings/0001437749-25-034293.md) | [(1.1) d](/filings/0001437749-26-009882.md) | [(2.3)](/filings/0001437749-26-017727.md) | [1.9 d](/filings/0001437749-26-028271.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001437749-24-034416.md) | [0.2 d](/filings/0001437749-25-009524.md) | [0.3](/filings/0001437749-25-016842.md) | [0.2 d](/filings/0001437749-25-026096.md) | [0.2 d](/filings/0001437749-25-034293.md) | [0.4 d](/filings/0001437749-26-009882.md) | [0.0](/filings/0001437749-26-017727.md) | [0.2 d](/filings/0001437749-26-028271.md) | [0.2 d](/filings/0001437749-25-034293.md) | [0.4 d](/filings/0001437749-26-009882.md) | [0.2](/filings/0001437749-26-017727.md) | [0.3 d](/filings/0001437749-26-028271.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.7](/filings/0001437749-23-032162.md) | [21.8](/filings/0001437749-24-016886.md) | [22.4](/filings/0001437749-24-026231.md) | [21.9](/filings/0001437749-24-034416.md) | [22.0](/filings/0001437749-25-016842.md) | [22.3](/filings/0001437749-25-026096.md) | [22.4](/filings/0001437749-25-034293.md) | [22.1](/filings/0001437749-26-017727.md) | [22.3](/filings/0001437749-26-028271.md) | [22.9](/filings/0001437749-25-034293.md) | [22.3](/filings/0001437749-26-017727.md) | [22.4](/filings/0001437749-26-028271.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,026,433 at 2026-08-05, from the cover of the [10-Q filed 2026-08-18](/filings/0001437749-26-028271.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.